Amyotrophic Lateral Sclerosis (ALS) Market Report

Global and Region Amyotrophic Lateral Sclerosis (ALS) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：221
  • REPORT CODE：GMM957901
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Amyotrophic Lateral Sclerosis (ALS) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Amyotrophic Lateral Sclerosis (ALS)market, defines the market attractiveness level of Amyotrophic Lateral Sclerosis (ALS) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Amyotrophic Lateral Sclerosis (ALS) industry, describes the types of Amyotrophic Lateral Sclerosis (ALS) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Amyotrophic Lateral Sclerosis (ALS) market and the development prospects and opportunities of Amyotrophic Lateral Sclerosis (ALS) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Amyotrophic Lateral Sclerosis (ALS) market in Chapter 13.

    By Player:

    • Mylan Pharma

    • Apotex

    • Mitsubishi Tanabe Pharma

    • Lunan Pharma

    • Covis Pharma

    • Sun Pharma

    • Glemark Generics

    • Sanofi

    By Type:

    • Riluzole

    • Edaravone (Radicava)

    • Other

    By End-User:

    • Hospital

    • Drugs Store

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Amyotrophic Lateral Sclerosis (ALS) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Amyotrophic Lateral Sclerosis (ALS) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Amyotrophic Lateral Sclerosis (ALS) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Amyotrophic Lateral Sclerosis (ALS) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Amyotrophic Lateral Sclerosis (ALS) Market Analysis and Outlook to 2022

    • 7.1 Global Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    • 7.2 United States Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    • 7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    • 7.4 China Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    • 7.5 Japan Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    • 7.6 India Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    • 7.7 South Korea Amyotrophic Lateral Sclerosis (ALS) Consumption (2017-2022)

    8 Region and Country-wise Amyotrophic Lateral Sclerosis (ALS) Market Analysis and Outlook to 2028

    • 8.1 Global Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    • 8.2 United States Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    • 8.3 Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    • 8.4 China Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    • 8.5 Japan Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    • 8.6 India Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    • 8.7 South Korea Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast (2022-2028)

    9 Global Amyotrophic Lateral Sclerosis (ALS) Market Outlook by Types and Applications to 2022

    • 9.1 Global Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Riluzole Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Edaravone (Radicava) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Amyotrophic Lateral Sclerosis (ALS) Market Outlook by Types and Applications to 2028

    • 10.1 Global Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Riluzole Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Edaravone (Radicava) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Amyotrophic Lateral Sclerosis (ALS) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Amyotrophic Lateral Sclerosis (ALS) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Amyotrophic Lateral Sclerosis (ALS) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Amyotrophic Lateral Sclerosis (ALS) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Amyotrophic Lateral Sclerosis (ALS) Market Competitive Analysis

    • 14.1 Mylan Pharma

      • 14.1.1 Mylan Pharma Company Details

      • 14.1.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.2 Apotex

      • 14.2.1 Apotex Company Details

      • 14.2.2 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.3 Mitsubishi Tanabe Pharma

      • 14.3.1 Mitsubishi Tanabe Pharma Company Details

      • 14.3.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.4 Lunan Pharma

      • 14.4.1 Lunan Pharma Company Details

      • 14.4.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.5 Covis Pharma

      • 14.5.1 Covis Pharma Company Details

      • 14.5.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.6 Sun Pharma

      • 14.6.1 Sun Pharma Company Details

      • 14.6.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.7 Glemark Generics

      • 14.7.1 Glemark Generics Company Details

      • 14.7.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • 14.8 Sanofi

      • 14.8.1 Sanofi Company Details

      • 14.8.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Amyotrophic Lateral Sclerosis (ALS)

    • Figure Amyotrophic Lateral Sclerosis (ALS) Picture

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Consumption by Country (2017-2022)

    • Figure United States Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate (2017-2022)

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate (2017-2022)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate (2017-2022)

    • Figure Japan Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate (2017-2022)

    • Figure India Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Amyotrophic Lateral Sclerosis (ALS) Consumption and Growth Rate (2017-2022)

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast by Country (2022-2028)

    • Figure United States Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Amyotrophic Lateral Sclerosis (ALS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Riluzole Consumption and Growth Rate (2017-2022)

    • Figure Global Edaravone (Radicava) Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs Store Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Riluzole Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Edaravone (Radicava) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Export by Region (Top 5 Countries) (2017-2028)

    • Table Mylan Pharma (Foundation Year, Company Profile and etc.)

    • Table Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Apotex (Foundation Year, Company Profile and etc.)

    • Table Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Lunan Pharma (Foundation Year, Company Profile and etc.)

    • Table Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Covis Pharma (Foundation Year, Company Profile and etc.)

    • Table Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Sun Pharma (Foundation Year, Company Profile and etc.)

    • Table Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Glemark Generics (Foundation Year, Company Profile and etc.)

    • Table Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US